Csontritkulás: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• RANKL 1
• PI3K 0
• NRF2 0
• AKT 0
• CTNNB1 0
• MAPK 0
• SIRT1 0
• mTOR 0
• AMPK 0
• PPAR 0
• STAT3 0
• ERK 0
• NLRP3 0
• YAP 0
• GPX4 0
• GLP-1 1
• TP53 0
• STING 0
• TNF 0
• HIF-1 0
• JAK 0
• METTL3 0
• IL-6 0
• PTEN 0
• VEGF 0
• CXCR4 0
• JNK 0
• MMP-9 0
• ESR1 0
• IL-4 0
• MEK 0
• PINK1 0
• SGLT2 0
• APP 0
• COX-2 0
• CSF1R 0
• DPP-4 0
• FTO 0
• HMGB1 0
• IL-1 0
• KIT 1
• APOE 0
• CD40 0
• CGRP 0
• EGFR 0
• EZH2 0
• FOXP3 0
• MYC 0
• TFEB 0
• ACE2 0
• AXL 0
• BRAF 0
• BRCA1 0
• BRCA2 0
• BRD4 0
• CCR5 0
• CDK4/6 0
• FGFR 0
• G6PD 0
• HSP90 0

1+ intézményből 1, a friss publikációk és a nyitott vizsgálatok szerint rendezve. Ez nem minőségi rangsor.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NIA · F30

  Dissecting Age-related Changes in Stem Cell-based Bone-Gut Crosstalk

  University of California at Davis· Davis, Egyesült Államok· 43 752 USD awarded in fiscal year 2026· until 2029. szept.

• NIH NIA · R41

  EC16 Nanoparticles: Bridging Oral Health and Alzheimer's Prevention via FAST Nanotechnology

  Camellix, Llc· Evans, Egyesült Államok· 499 999 USD awarded in fiscal year 2026· until 2027. szept.

• NIH NIDCR · R44

  Use of an Innovative Pre-Formed Structural Scaffold for Reconstruction of Segmental Bone Loss in a Zygomaticomaxillary Complex Model

  Revbio, Inc.· Lowell, Egyesült Államok· 1 276 407 USD awarded in fiscal year 2026· until 2028. aug.

• NIH NIA · R44

  Fibrinogen-coated albumin spheres to accelerate bone healing in older adults

  Fibroplate, Inc.· Las Vegas, Egyesült Államok· 1 162 390 USD awarded in fiscal year 2026· until 2028. máj.

• NIH NIAMS · R21

  Remodeling of the osteocyte pericellular matrix during unloading

  University of Colorado· Boulder, Egyesült Államok· 157 521 USD awarded in fiscal year 2026· until 2028. aug.

• European Commission (Horizon Europe) · HORIZON-ERC

  Extending Female Reproductive Longevity: Neurovascular Control of the Ovarian Reserve (dOvary)

  Academisch Ziekenhuis Leiden· Leiden, Hollandia· EU contribution 2 500 000 EUR· until 2031. okt.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Predicting Effective Plant Phosphopeptide–Calcium Formulations Using Machine Learning for Ca/Vitamin D3 and K2 Supplement Development via Pickering Emulsion (CaVita-Phos)

  Christian-Albrechts-Universitaet Zu Kiel· Kiel, Németország· EU contribution 202 125 EUR· until 2028. szept.· 2 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  A Human Muscle-Bone Organoid-on-Chip to Study Bone Mechano- Adaptation via Optogenetic Control (BONE-TUNE)

  Eidgenoessische Technische Hochschule Zuerich· Zuerich, Svájc· EU contribution 292 119 EUR· until 2028. jún.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  Hypothalamic cell changes during menopause: the neuroendocrine origin of its metabolic alterations (HypoPause)

  Universidad de Santiago de Compostela· Santiago De Compostela, Spanyolország· EU contribution 1 498 325 EUR· until 2031. jan.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF

  EVOLUTIONARY MECHANISMS OF AGE-RELATED BONE LOSS ACROSS THE HUMAN AND HOMINID SKELETON (STAND UP)

  Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev· Munchen, Németország· EU contribution 401 232 EUR· until 2028. dec.· 3 countries

10 of 504 running projects, newest first. Listed amounts together: 231,1 M USD + 61,7 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 17
• Organoids 1
• Mendelian Randomization Analysis 90
• CRISPR-Cas Systems 1
• Gene Expression Profiling 60
• Sequence Analysis, RNA 5
• Whole Genome Sequencing 1
• Exome Sequencing 6
• Proteomics 23
• Metabolomics 25
• Mass Spectrometry 7
• Flow Cytometry 6
• Immunohistochemistry 10
• Xenograft Model Antitumor Assays 3
• Magnetic Resonance Imaging 73
• Machine Learning 79
• Deep Learning 38
• Cohort Studies 237
• Genome-Wide Association Study 83

• Vitamin D3 Treatment Alters Thyroid Functional Morphology in Orchidectomized Rat Model of Osteoporosis.

  Int J Mol Sci, 2022. jan.

• Melatonin is a potential drug for the prevention of bone loss during space flight.

  J Pineal Res, 2019. júl.

• Central role of the proximal tubular αKlotho/FGF receptor complex in FGF23-regulated phosphate and vitamin D metabolism.

  Sci Rep, 2018. máj.

• The effect of simvastatin treatment on bone repair of femoral fracture in animal model.

  Growth Factors, 2015. márc.

• Does coenzyme-Q have a protective effect against atorvastatin induced myopathy? A histopathological and immunohistochemical study in albino rats.

  Histol Histopathol, 2014. nov.

• Effect of implantation of biodegradable magnesium alloy on BMP-2 expression in bone of ovariectomized osteoporosis rats.

  Mater Sci Eng C Mater Biol Appl, 2013. máj.

• Curcumin inhibits inflammatory response and bone loss during experimental periodontitis in rats.

  Acta Odontol Scand, 2012. máj.

• Simvastatin induces estrogen receptor-alpha expression in bone, restores bone loss, and decreases ERα expression and uterine wet weight in ovariectomized rats.

  J Bone Miner Metab, 2010. nov.

• Mandibular bone alterations of ovariectomized rats under vitamin D insufficiency.

  Histol Histopathol, 2008. ápr.

• Bone loss induced by dietary magnesium reduction to 10% of the nutrient requirement in rats is associated with increased release of substance P and tumor necrosis factor-alpha.

  J Nutr, 2004. jan.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.